Terms: = Lymphoma AND LMO2, RBTN2, 4005, ENSG00000135363, P25791, TTG2, RBTNL1, RHOM2
154 results:
1. Diagnostic utility of lmo2 immunohistochemistry in distinguishing T-lymphoblastic leukemia/lymphoma from thymoma.
Bansal D; Pasricha S; Gupta G; Sharma A; Durga G; Kamboj M; Mehta A
Indian J Pathol Microbiol; 2024; 67(1):141-144. PubMed ID: 38358204
[TBL] [Abstract] [Full Text] [Related]
2. ZNF683 marks a CD8
Parry EM; Lemvigh CK; Deng S; Dangle N; Ruthen N; Knisbacher BA; Broséus J; Hergalant S; Guièze R; Li S; Zhang W; Johnson C; Long JM; Yin S; Werner L; Anandappa A; Purroy N; Gohil S; Oliveira G; Bachireddy P; Shukla SA; Huang T; Khoury JD; Thakral B; Dickinson M; Tam C; Livak KJ; Getz G; Neuberg D; Feugier P; Kharchenko P; Wierda W; Olsen LR; Jain N; Wu CJ
Cancer Cell; 2023 Oct; 41(10):1803-1816.e8. PubMed ID: 37738974
[TBL] [Abstract] [Full Text] [Related]
3. Emerging entities: high-grade/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop.
Quintanilla-Martinez L; Laurent C; Soma L; Ng SB; Climent F; Ondrejka SL; Zamo A; Wotherspoon A; de Leval L; Dirnhofer S; Leoncini L
Virchows Arch; 2023 Sep; 483(3):281-298. PubMed ID: 37555980
[TBL] [Abstract] [Full Text] [Related]
4. Value of GCET1, HGAL (GCET2), and lmo2 in the Determination of Germinal Center Phenotype in Diffuse Large B-cell lymphoma.
Berker N; Yeğen G; Özlük Y; Doğan Ö
Turk J Haematol; 2023 Aug; 40(3):162-173. PubMed ID: 37519110
[TBL] [Abstract] [Full Text] [Related]
5. PARP inhibitor exerts an anti-tumor effect via lmo2 and synergizes with cisplatin in natural killer/T cell lymphoma.
Wu J; Shi C; Li H; Song W; Huang S; Zhang J; Li W; Li Z; Zhang M
BMC Med; 2023 Jul; 21(1):253. PubMed ID: 37442994
[TBL] [Abstract] [Full Text] [Related]
6. [Establishment and Clinical Significance of Prognostic Nomogram Model for Diffuse Large B-Cell lymphoma Based on Immunohistochemistry Markers and International Prognostic Index Scores].
Xu YW; Zhou YL; Kong FC; Chen ZW; Li F
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):753-761. PubMed ID: 37356936
[TBL] [Abstract] [Full Text] [Related]
7. STAT5 activation promotes progression and chemotherapy resistance in early T-cell precursor acute lymphoblastic leukemia.
Tremblay CS; Saw J; Boyle JA; Haigh K; Litalien V; McCalmont H; Evans K; Lock RB; Jane SM; Haigh JJ; Curtis DJ
Blood; 2023 Jul; 142(3):274-289. PubMed ID: 36989489
[TBL] [Abstract] [Full Text] [Related]
8. Overexpression of lmo2 initiates T-lymphoblastic leukemia via impaired thymocyte competition.
Abdulla HD; Alserihi R; Flensburg C; Abeysekera W; Luo MX; Gray DHD; Liu X; Smyth GK; Alexander WS; Majewski IJ; McCormack MP
J Exp Med; 2023 Jun; 220(6):. PubMed ID: 36920307
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic utility of key copy number alterations in T cell acute lymphoblastic leukemia.
Kumari S; Ali MS; Singh J; Arora M; Verma D; Pandey AK; Benjamin M; Bakhshi S; Palanichamy JK; Sharma A; Singh I; Tanwar P; Singh AR; Pushpam D; Qamar I; Chopra A
Hematol Oncol; 2022 Oct; 40(4):577-587. PubMed ID: 35644022
[TBL] [Abstract] [Full Text] [Related]
10. Transcriptome-wide subtyping of pediatric and adult T cell acute lymphoblastic leukemia in an international study of 707 cases.
Dai YT; Zhang F; Fang H; Li JF; Lu G; Jiang L; Chen B; Mao DD; Liu YF; Wang J; Peng LJ; Feng C; Chen HF; Mu JX; Zhang QL; Wang H; Ariffin H; Moy TA; Wang JH; Lou YJ; Chen SN; Wang Q; Liu H; Shan Z; Matsumura I; Miyazaki Y; Yasuda T; Dou LP; Yan XJ; Yan JS; Yeoh AE; Wu DP; Kiyoi H; Hayakawa F; Jin J; Wang SY; Sun XJ; Mi JQ; Chen Z; Huang JY; Chen SJ
Proc Natl Acad Sci U S A; 2022 Apr; 119(15):e2120787119. PubMed ID: 35385357
[TBL] [Abstract] [Full Text] [Related]
11. lmo2 expression is frequent in T-lymphoblastic leukemia and correlates with survival, regardless of T-cell stage.
Latchmansingh KA; Wang X; Verdun RE; Marques-Piubelli ML; Vega F; You MJ; Chapman J; Lossos IS
Mod Pathol; 2022 Sep; 35(9):1220-1226. PubMed ID: 35322192
[TBL] [Abstract] [Full Text] [Related]
12. Human Germinal Center-associated lymphoma (HGAL) Is a Reliable Marker of Normal and Neoplastic Follicular Helper T Cells Including Angioimmunoblastic T-Cell lymphoma.
Koo M; Zhang J; Tan B; Kurzer J; Gratzinger D; Zhao S; Suarez C; Lossos IS; Warnke RA; Natkunam Y
Am J Surg Pathol; 2022 May; 46(5):643-654. PubMed ID: 34907996
[TBL] [Abstract] [Full Text] [Related]
13. MiR-223 Suppresses Proliferation and Promotes Apoptosis of Diffuse Large B-Cell lymphoma Cells Through lmo2 and MAPK Signaling Pathway.
Zhang Y; Zhang J
J BUON; 2021; 26(2):580-586. PubMed ID: 34077008
[TBL] [Abstract] [Full Text] [Related]
14. Optical genome mapping, a promising alternative to gold standard cytogenetic approaches in a series of acute lymphoblastic leukemias.
Lestringant V; Duployez N; Penther D; Luquet I; Derrieux C; Lutun A; Preudhomme C; West M; Ouled-Haddou H; Devoldere C; Marolleau JP; Garçon L; Jedraszak G; Ferret Y
Genes Chromosomes Cancer; 2021 Oct; 60(10):657-667. PubMed ID: 33982372
[TBL] [Abstract] [Full Text] [Related]
15. Lack of expression of lmo2 clone SP51 identifies MYC rearrangements in aggressive large B-cell lymphomas.
Vazquez I; Papaleo N; Lop J; Puiggros A; Sanchez-Gonzalez B; Diez-Feijoo R; Gimeno E; Andrade-Campos M; Salar A; Espinet B; Salido M; Tapia G; Carreras J; Ferrer A; Arenillas L; Calvo X; Colomo L
Virchows Arch; 2021 Dec; 479(6):1073-1078. PubMed ID: 33811533
[TBL] [Abstract] [Full Text] [Related]
16. New genetic prognostic biomarkers in primary central nervous system lymphoma (PCNSL).
Gomes Candido Reis D; Levy D; Lage LAPC; Culler HF; Rocha V; Bydlowski SP; Nogueira Zerbini MC; Pereira J
Brain Behav; 2021 Apr; 11(4):e02061. PubMed ID: 33591648
[TBL] [Abstract] [Full Text] [Related]
17. Large-scale circular RNA deregulation in T-ALL: unlocking unique ectopic expression of molecular subtypes.
Buratin A; Paganin M; Gaffo E; Dal Molin A; Roels J; Germano G; Siddi MT; Serafin V; De Decker M; Gachet S; Durinck K; Speleman F; Taghon T; Te Kronnie G; Van Vlierberghe P; Bortoluzzi S
Blood Adv; 2020 Dec; 4(23):5902-5914. PubMed ID: 33259601
[TBL] [Abstract] [Full Text] [Related]
18. LIM domain only 2 (lmo2) expression distinguishes T-lymphoblastic leukemia/lymphoma from indolent T-lymphoblastic proliferations.
Brar N; Butzmann A; Kumar J; Peerani R; Morgan EA; Grigoriadis G; Kumar B; Tatarczuch RM; Warnke RA; Ohgami RS
Histopathology; 2020 Dec; 77(6):984-988. PubMed ID: 32526041
[TBL] [Abstract] [Full Text] [Related]
19. Design of a Comprehensive Fluorescence in Situ Hybridization Assay for Genetic Classification of T-Cell Acute Lymphoblastic Leukemia.
La Starza R; Pierini V; Pierini T; Nofrini V; Matteucci C; Arniani S; Moretti M; Lema Fernandez AG; Pellanera F; Di Giacomo D; Storlazzi TC; Vitale A; Gorello P; Sammarelli G; Roti G; Basso G; Chiaretti S; Foà R; Schwab C; Harrison CJ; Van Vlierberghe P; Mecucci C
J Mol Diagn; 2020 May; 22(5):629-639. PubMed ID: 32142900
[TBL] [Abstract] [Full Text] [Related]
20. The life and death of the germinal center.
Gars E; Butzmann A; Ohgami R; Balakrishna JP; O'Malley DP
Ann Diagn Pathol; 2020 Feb; 44():151421. PubMed ID: 31751845
[TBL] [Abstract] [Full Text] [Related]
[Next]
